Form 4 for EW Edwards Lifesciences
Accepted 2025-05-09 00:00:00 ET · period of report 2025-05-08 · accession 0001225208-25-004946 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2025-05-09 | 2025-05-08 | EW | Dahl Andrew M. | SVP, Corp. Ctrl | A - Grant | $0.00 | +3,335 | 8,107 | +70% | $0 |
| D | 2025-05-09 | 2025-05-08 | EW | Dahl Andrew M. | SVP, Corp. Ctrl | A - Grant | $0.00 | +5,670 | 5,670 | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-05-08 | A | A | 3,335 | $0.00 | 8,106.53 | D | — | — | (F1) These restricted stock units were granted on May 8, 2025 under the Edwards Lifesciences Corporation Long-Term Stock Incentive Compensation Program and are scheduled to become vested and exercisable commencing one year after the grant date in four equal annual installments. |
| 2 | Derivative | Employee Stock Option (Right to Acquire) | 2025-05-08 | A | A | 5,670 | $0.00 | 5,670 | D | $74.63 · 2026-05-08 to 2032-05-07 | 5,670 Common Stock | (F2) These options were granted on May 8, 2025 under the Edwards Lifesciences Corporation Long-Term Stock Incentive Compensation Program and are scheduled to become vested and exercisable commencing one year after the grant date in four equal annual installments. |